IXT-m200

· InterveXion Therapeutics, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IXT-m200, covering 2023-06-01 to 2024-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 [Phase 2]